Largest Biotechnology companies in Netherlands by Market Capitalization

This ranking features the largest 7 Biotechnology companies in Netherlands ranked by Market Capitalization, totaling a Market Capitalization of USD 17.86 B, for June 23, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Netherlands has the highest Market Capitalization ?

The Biotechnology company in Netherlands with the highest Market Capitalization is Qiagen N.V. (NYSE: QGEN) at USD 10.13 B.
Which Biotechnology company in Netherlands has the lowest Market Capitalization ?

The Biotechnology company in Netherlands with the lowest Market Capitalization is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD 35.25 M.

What are the top 10 Biotechnology companies in Netherlands by Market Capitalization ?

The top 10 Biotechnology companies in Netherlands by Market Capitalization are Qiagen N.V., Merus N.V., NewAmsterdam Pharma Company N.V., uniQure N.V., Pharming Group N.V., ProQR Therapeutics N.V. and LAVA Therapeutics N.V..
What are the bottom 10 Biotechnology companies in Netherlands by Market Capitalization ?

The bottom 10 Biotechnology companies in Netherlands by Market Capitalization are LAVA Therapeutics N.V., ProQR Therapeutics N.V., Pharming Group N.V., uniQure N.V., NewAmsterdam Pharma Company N.V., Merus N.V. and Qiagen N.V..